New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
07:37 EDTNSTGNanoString reports preliminary Q4 revenue about $10.1M, consensus $9.61M.
NanoString anticipates instrument revenue of approximately $5.3M for Q4, representing approximately 112% growth compared to $2.5M for 4Q12. The company's installed base of nCounter Analysis Systems stood at over 180 systems as of the end of 2013. Consumables revenue is anticipated to be approximately $4.4M in Q4, representing approximately 19% growth over the $3.7M reported for 4Q12.
News For NSTG From The Last 14 Days
Check below for free stories on NSTG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
16:02 EDTNSTGNanoString introduces novel gene expression panel for immuno-oncology research
NanoString Technologies announced the introduction of a new highly multiplexed gene expression panel for the nCounter Analysis System, the PanCancer Immune Profiling Panel. This novel panel will enable researchers to create profiles of the human immune response in all cancer types, potentially accelerating the discovery and development of drugs, therapies and predictive biomarker signatures for immunotherapy treatment response.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use